BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16196516)

  • 1. Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component.
    Kim MJ; Gong G; Joo HJ; Ahn SH; Ro JY
    Arch Pathol Lab Med; 2005 Oct; 129(10):1277-82. PubMed ID: 16196516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive micropapillary carcinoma of the breast: a prognostic study.
    Paterakos M; Watkin WG; Edgerton SM; Moore DH; Thor AD
    Hum Pathol; 1999 Dec; 30(12):1459-63. PubMed ID: 10667424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study.
    De la Cruz C; Moriya T; Endoh M; Watanabe M; Takeyama J; Yang M; Oguma M; Sakamoto K; Suzuki T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
    Pathol Int; 2004 Feb; 54(2):90-6. PubMed ID: 14720138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Micropapillary Component Ratio on the Prognosis of Patients With Invasive Micropapillary Breast Carcinoma.
    Kaya C; Uçak R; Bozkurt E; Ömeroğlu S; Kartal K; Yazıcı P; İdiz UO; Mihmanlı M
    J Invest Surg; 2020 Jan; 33(1):31-39. PubMed ID: 29843540
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
    Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
    Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
    Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
    Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma.
    Lotan TL; Ye H; Melamed J; Wu XR; Shih IeM; Epstein JI
    Am J Surg Pathol; 2009 Jul; 33(7):1037-41. PubMed ID: 19238079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
    Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
    Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T; Gaffey TA; Visscher DW; Kay PA; Minato H; Serizawa H; Lewis JE
    Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.
    Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
    Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive ductal carcinoma of no special type and its corresponding lymph node metastasis: do they have the same immunophenotypic profile?
    Fulga V; Rudico L; Balica AR; Cimpean AM; Saptefrati L; Raica M
    Pol J Pathol; 2015 Mar; 66(1):30-7. PubMed ID: 26017877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival.
    Kuba S; Ohtani H; Yamaguchi J; Hayashi H; Uga T; Kanematsu T; Shimokawa I
    Virchows Arch; 2011 Feb; 458(2):159-69. PubMed ID: 21221635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast.
    Kuroda H; Sakamoto G; Ohnisi K; Itoyama S
    Breast Cancer; 2004; 11(3):301-6. PubMed ID: 15550850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity.
    Walsh MM; Bleiweiss IJ
    Hum Pathol; 2001 Jun; 32(6):583-9. PubMed ID: 11431712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.